Groundbreaking initiative will track dementia onset, progress in Down syndrome volunteers.   The National Institutes of Health has launched a new initiative to identify biomarkers and track the progression of Alzheimer’s in people with Down syndrome. Many people with Down syndrome have Alzheimer’s-related brain changes in their 30s that can lead to dementia in their 50s and 60s. Little is known about how the disease progresses in this vulnerable group. The NIH Biomarkers of Alzheimer’s Disease in Adults with Down Syndrome Initiative will support teams of researchers using brain imaging, as well as fluid and tissue biomarkers in research that may one day lead to effective interventions for all people with dementia.

Related posts:

  1. New classification criteria released for research on Sjogren’s Syndrome An international team of researchers released new classification criteria for the common autoimmune condition Sjogren’s syndrome. Classification criteria are the consensus opinion of a group of experts that researchers use in clinical studies to confirm a previous diagnosis and/or subclassify patients who have the same type of a given condition....
  2. Medicare, Medicare Card, NIH and Wellcome Trust Announce Partnership To Support Population-based Genome Studies in Africa The National Institutes of Health, an agency of the U.S. Department of Health and Human Services, and the Wellcome Trust, a global charity based in London, today announced a partnership to support population-based genetic studies in Africa of common, non-communicable disorders such as heart disease and cancer, as well as communicable diseases such as malaria. […]...
  3. Medicare Card, NIH-supported study finds U.S. dementia care costs as high as $215 billion in 2010 Medicare Card, NIH-supported study finds U.S. dementia care costs as high as $215 billion in 2010...
  4. Medicare Card, NIH-funded research lays groundwork for next-generation prosthetics Medicare Card, NIH-funded research lays groundwork for next-generation prosthetics...
  5. Medicare Card, Genotype-Tissue Expression project expands functional studies of genomic variation Medicare Card, Genotype-Tissue Expression project expands functional studies of genomic variation...
  6. Researchers identify gene variant in Proteus syndrome A team of researchers has identified the genetic mutation that causes Proteus syndrome, a rare disorder in which tissue and bone grows massively out of proportion. The discovery, which has implications for potential drug therapies and even cancer, appears in the July 27, 2011, early online edition of the New England Journal of Medicine. The […]...
  7. Down syndrome consortium formed National Institutes of Health has joined with organizations interested in Down syndrome to form a consortium that will foster the exchange of information on biomedical and biobehavioral research on the chromosomal condition....
  8. XMRV and related viruses not confirmed in blood of healthy donors or chronic fatigue syndrome patients A study supported by the U.S. Department of Health and Human Services could not validate or confirm previous research findings that suggested the presence of one of several viruses in blood samples of people living with chronic fatigue syndrome. The new study also could not find the viruses in blood samples of healthy donors who […]...
  9. Medicare Card, NIH-funded study suggests brain is hard-wired for chronic pain Medicare Card, NIH-funded study suggests brain is hard-wired for chronic pain...
  10. Medicare Card, Versatile proteins could be new target for Alzheimer’s drugs Medicare Card, Versatile proteins could be new target for Alzheimer's drugs...
  11. Medicare Card, Impaired clearance, not overproduction of toxic proteins, may underlie Alzheimer’sdisease In Alzheimer’s disease, a protein fragment called beta-amyloid accumulates at abnormally high levels in the brain. Now researchers funded by the National Institutes of  Health have found that in the most common, late-onset form of Alzheimer’s disease, beta-amyloid is produced in the brain at a normal rate but is not cleared, or removed from the […]...
  12. Medicare, NHLBI launches program on early cystic fibrosis lung disease Researchers will study pre-symptomatic lung disease in infants and young children with cystic fibrosis (CF), under a new grant program of the National Heart, Lung, and Blood Institute (NHLBI). Results could reveal how CF develops, which in turn could lead to interventions that delay or prevent disease progression. The studies also could provide critical information […]...
  13. Medicare – Occasional Forgetfulness Chances are you’ve walked into a room and forgotten why you went there. And misplaced your keys or eyeglasses at least a few times. Many people worry about these memory lapses. They fear they’re heading toward a serious condition like Alzheimer’s disease, an irreversible brain illness....
  14. Medicare Card, Learn Symptoms and Treatment Options for Alzheimer’s Disease Medicare Card, Learn Symptoms and Treatment Options for Alzheimer's Disease...
  15. Medicare Card, Repurposed experimental cancer drug restores brain function in mouse models of Alzheimer’s disease Scientists have found that a compound originally developed as a cancer therapy potentially could be used to treat Alzheimer’s disease. The team demonstrated that the drug, saracatinib, restores memory loss and reverses brain problems in mouse models of Alzheimer’s, and now the researchers are testing saracatinib’s effectiveness in humans. The study was funded by the […]...